Table 1 Baseline demographic and biochemical characteristics
| Â | Ezetimibe + rosuvastatin (n = 34) | Rosuvastatin alone (n = 36) | p-value |
|---|---|---|---|
Demographics | |||
 Age, years | 50.3 (12.9) | 52.5 (19.1) | 0.647 |
 Female; n (%) | 12 (35.3) | 18 (50.0) | 0.214 |
 Weight, kg | 78.2 (19.3) | 77.2 (15.5) | 0.958 |
 BMI, kg/m2 | 27.7 (6.6) | 28.6 (3.6) | 0.196 |
 Waist circumference, cm | 95.0 (15.3) | 96.5 (11.1) | 0.685 |
 Presence of diabetes, n (%) | 26 (72.2) | 26 (76.5) | 0.684 |
 Seated SBP, mmHg | 126.0 (11.0) | 123.0 (13.0) | 0.676 |
 Seated DBP, mmHg | 81.0 (11.0) | 80.5 (13.0) | 0.851 |
Biochemical profile | |||
 ALT, IU/l | 37.5 (30.0) | 30.0 (22.0) | 0.099 |
 AST, IU/l | 24.5 (13.0) | 24.5 (13.0) | 0.706 |
 Platelets, ×103/μl | 263.0 (89.0) | 258.5 (77.0) | 0.307 |
 Alk Phos, U/l | 64.0 (22.0) | 68.5 (36.0) | 0.121 |
 GGT, U/l | 42.5 (36.0) | 35.0 (33.0) | 0.347 |
 Total bilirubin, mg/dl | 0.6 (0.3) | 0.7 (0.4) | 0.557 |
 Glucose, mg/dl | 116.0 (26.0) | 114.0 (35.0) | 0.958 |
 Insulin, uU/ml | 12.4 (10.3) | 14.7 (9.1) | 0.171 |
 HbA1c, % | 6.4 (0.5) | 6.4 (0.9) | 0.548 |
 FFA, mmol/l | 509.0 (307.0) | 532.5 (260.0) | 0.541 |
 HOMA-IR | 3.5 (3.5) | 3.9 (2.7) | 0.166 |
 HOMA-beta | 85.5 (70.3) | 99.6 (60.4) | 0.347 |
 Triglycerides, mg/dl | 176.5 (143.0) | 217.5 (159.0) | 0.177 |
 HDL, mg/dl | 45.0 (16.0) | 42.0 (8.0) | 0.266 |
 LDL, mg/dl | 115.3 (64.7) | 111.2 (39.9) | 0.742 |
 CRP, mg/l | 1.5 (1.8) | 1.5 (1.5) | 0.897 |
 eGFR, CKD-EPI equation | 102.0 (23.0) | 95.5 (28.0) | 0.347 |